Xilio Therapeutics, Inc. Quarterly Common Stock, Par or Stated Value Per Share in USD/shares from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD/shares
Description
Face amount or stated value per share of common stock.
Summary
Xilio Therapeutics, Inc. quarterly Common Stock, Par or Stated Value Per Share history and growth rate from Q4 2020 to Q3 2024.
  • Xilio Therapeutics, Inc. Common Stock, Par or Stated Value Per Share for the quarter ending September 30, 2024 was 0 USD/shares, unchanged year-over-year.
Common Stock, Par or Stated Value Per Share, Quarterly (USD/shares)
Common Stock, Par or Stated Value Per Share, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $0 $0 0% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $0 $0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $0 $0 0% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $0 $0 0% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $0 $0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $0 $0 0% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $0 $0 0% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $0 $0 0% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $0 $0 0% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $0 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $0 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $0 $0 0% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $0 Sep 30, 2021 10-Q 2021-12-02
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.